CD133 Antibody (3F10) - BSA Free

Prominin 1 (CD133) is expressed on primitive hematopoietic stem and progenitor cells, retinoblastoma, hemangioblasts, and neural stem cells as well as on developing epithelium. The CD133 positive fraction of human bone marrow, cord blood and peripheral blood have been shown to efficiently engraft in xenotransplantation models, and have been shown to contain the majority of the granulocyte/macrophage precursors, NOD/SCID repopulating cells and CD34 + dendritic cell precursors.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 3 applications: ICC/IF, IF/IHC, IHC-P.

Showing Publications 1 - 4 of 4.

Publications using NBP2-37741	Applications	Species
Jun S, Yoon H, Yoon J et al. The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers Cancers 2021-06-11 [PMID: 34208132] (IF/IHC, Human)	IF/IHC	Human
Klose J, Schmitt A, Pernthaler J et al. Still proliferating CD44+/Ki67+ tumor cells after neoadjuvant radiochemotherapy identify rectal cancer patients with poor survival European Journal of Surgical Oncology 2021-03-01 [PMID: 33814238] (IHC-P, Human)	IHC-P	Human
Jun SY, Jeon SJ, Yoon JY et al. The positive correlation of TIPRL with LC3 and CD133 contributes to cancer aggressiveness: potential biomarkers for early liver cancer Sci Rep 2019-11-14 [PMID: 31727942] (IF/IHC, Human)	IF/IHC	Human
Acosta, SA;Lee, JY;Nguyen, H;Kaneko, Y;Borlongan, CV; Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome Stem Cell Rev 2019-04-01 [PMID: 30739275] (ICC/IF, Human)	ICC/IF	Human

Array NBP2-37741

• CD133 Antibodies
• CD133 Proteins